Read our insights and commentary about industry news and innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.
Showing 3 of 7 posts
August 5, 2020 | Blog
Since its inception over 30 years ago, the 340B drug pricing program policy has evolved allowing for unprecedented expansion and influence. With this it has also become highly contested, especially in recent years as more legislation has been put forward to close 340B loopholes.
August 5, 2020 | Infographics
June 5, 2019 | Videos
US Market Access Trends: CBPartners' Andrew Gould asks a panel of US payers what is the likelihood of increased site-of-care-restrictions is among them.